33 results
20-F/A
2023 FY
IPCIF
Intellipharmaceutics International Inc.
6 Feb 24
Annual report (foreign) (amended)
12:00am
of viruses or other contagions or epidemic diseases could have a material adverse effect on the Company. The ongoing COVID-19 outbreak and pandemic … financial problems which have continued, coupled with the effects of the Covid-19 pandemic. It is not possible to reliably estimate the length and severity
6-K
EX-99.2
IPCIF
Intellipharmaceutics International Inc.
16 Oct 23
Current report (foreign)
5:23pm
activities and staffing levels significantly due to ongoing financial problems which have continued, coupled with the effects of the Covid-19 pandemic
6-K
EX-99.1
IPCIF
Intellipharmaceutics International Inc.
16 Oct 23
Current report (foreign)
5:23pm
problems which have continued, coupled with the effects of the Covid-19 pandemic. It is not possible to reliably estimate the length and severity … levels significantly due to ongoing financial problems which have continued, coupled with the effects of the Covid-19 pandemic. It is not possible
6-K
EX-99.2
IPCIF
Intellipharmaceutics International Inc.
26 Sep 23
Current report (foreign)
5:29pm
and staffing levels significantly due to ongoing financial problems which have continued, coupled with the effects of the Covid-19 pandemic
6-K
EX-99.1
IPCIF
Intellipharmaceutics International Inc.
26 Sep 23
Current report (foreign)
5:29pm
problems which have continued, coupled with the effects of the Covid-19 pandemic. It is not possible to reliably estimate the length and severity … with the effects of the Covid-19 pandemic. It is not possible to reliably estimate the length and severity of the developments and impact
6-K
EX-99.2
aeow3 kiivdoo1y
26 Sep 23
Current report (foreign)
5:23pm
6-K
EX-99.1
68ohx65o 9zjswaxz
26 Sep 23
Current report (foreign)
5:23pm
6-K
EX-99.2
8uxw 1a6op60kzzmuop6
14 Oct 22
Current report (foreign)
4:22pm
6-K
EX-99.1
xrxrazqn
14 Oct 22
Current report (foreign)
4:22pm
6-K
EX-99.1
i3jp7nxk93gb
21 Jul 22
Current report (foreign)
5:28pm
6-K
EX-99.2
yq8e2olck1i
21 Jul 22
Current report (foreign)
5:28pm
20-F/A
zy64mb fq0kdk
6 May 22
Annual report (foreign) (amended)
7:54pm
6-K
EX-99.2
uoho0wi4i54fvxplc8dg
29 Apr 22
Annual & Special Meeting of Shareholders
11:43am
6-K
EX-99.2
jcj5re
14 Apr 22
Current report (foreign)
4:46pm
6-K
EX-99.1
p3vfx89ev7
14 Apr 22
Current report (foreign)
4:46pm
6-K
EX-99.2
rsdrnns19iq2ukyg0hq
1 Mar 22
Current report (foreign)
8:04am
6-K
EX-99.1
lp8e b9drfzt9n6wrp4
1 Mar 22
Current report (foreign)
8:04am
6-K
EX-99.2
ddyqwyci820q5n1
6 Jan 22
Annual & Special Meeting of Shareholders
5:19pm